This is a misidentified cell line with no known authentic stock.
This BioSample record was created using the International Cell Line Authentication Committee (ICLAC) Register of Cross-contaminated or Misidentified Cell Lines, version 9.0. See the ICLAC link below for more information. For questions, contact info@iclac.org.
To cite the ICLAC register or learn more about contaminated cell lines, please refer to: Capes-Davis A, Theodosopoulos G, Atkin I, Drexler HG, Kohara A, Macleod RA, Masters JR, Nakamura Y, Reid YA, Reddel RR, Freshney RI (2010) Check your cultures! A list of cross-contaminated or misidentified cell lines. Int J Cancer 127: 1-8. PMID: 20143388.
Note: Reviewed by ICLAC (ref: 160714). HAC15 was originally described as a novel adrenal cortex carcinoma cell line [source: Parmar et al 2008, PMID 18713819]. A later review noted that SNP analysis had been performed for HAC15 and demonstrated that it was actually a derivative of NCI-H295R [source: Wang and Rainey 2012, PMID 21924324]. An STR profile of HAC15 held at ATCC (CRL-3301) confirmed that HAC15 corresponded to NCI-H295R.